Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Wilkin

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
American Journal of Clinical Pathology|September 14, 2017
Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected WomenZizipho Z A Mbulawa, Timothy Wilkin, Bridgette J Goeieman, et al.
Open Forum Infectious Diseases|August 15, 2020
Sex Differences in CMV Replication and HIV Persistence During Suppressive ARTSara Gianella, Sarah McDonald Tran, Sheldon Morris, et al.
Journal of Lower Genital Tract Disease|November 19, 2015
An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan AfricaJenell S Coleman, Michelle S Cespedes, Susan Cu-Uvin, et al.
Journal of Clinical Microbiology|June 5, 2009
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virionsNoriaki Hosoya, Zhaohui Su, Timothy Wilkin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2016
A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected AdultsGregory D Huhn, Pablo Tebas, Joel Gallant, et al.
Journal of Biomolecular Structure & Dynamics|March 18, 2021
Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infectionDennis C Copertino, Bruno C Casado Lima, Rodrigo R R Duarte, et al.
Lancet (London, England)|July 10, 2007
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trialJosé Valdez Madruga, Pedro Cahn, Beatriz Grinsztejn, et al.
Sexually Transmitted Diseases|March 13, 2018
High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298Ross D Cranston, Michelle S Cespedes, Pawel Paczuski, et al.
Open Forum Infectious Diseases|August 21, 2023
Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence BarriersWanyi Chen, Monica Gandhi, Paul E Sax, et al.
AIDS (London, England)|October 4, 2012
Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and womenElizabeth A Stier, Stephen E Goldstone, Mark H Einstein, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
American Journal of Clinical Pathology|September 14, 2017
Prevalence of Anal Human Papillomavirus (HPV) and Performance of Cepheid Xpert and Hybrid Capture 2 (hc2) HPV Assays in South African HIV-Infected WomenZizipho Z A Mbulawa, Timothy Wilkin, Bridgette J Goeieman, et al.
Open Forum Infectious Diseases|August 15, 2020
Sex Differences in CMV Replication and HIV Persistence During Suppressive ARTSara Gianella, Sarah McDonald Tran, Sheldon Morris, et al.
Journal of Lower Genital Tract Disease|November 19, 2015
An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan AfricaJenell S Coleman, Michelle S Cespedes, Susan Cu-Uvin, et al.
Journal of Clinical Microbiology|June 5, 2009
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virionsNoriaki Hosoya, Zhaohui Su, Timothy Wilkin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2016
A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected AdultsGregory D Huhn, Pablo Tebas, Joel Gallant, et al.
Journal of Biomolecular Structure & Dynamics|March 18, 2021
Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infectionDennis C Copertino, Bruno C Casado Lima, Rodrigo R R Duarte, et al.
Lancet (London, England)|July 10, 2007
Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trialJosé Valdez Madruga, Pedro Cahn, Beatriz Grinsztejn, et al.
Sexually Transmitted Diseases|March 13, 2018
High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298Ross D Cranston, Michelle S Cespedes, Pawel Paczuski, et al.
Open Forum Infectious Diseases|August 21, 2023
Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence BarriersWanyi Chen, Monica Gandhi, Paul E Sax, et al.
AIDS (London, England)|October 4, 2012
Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and womenElizabeth A Stier, Stephen E Goldstone, Mark H Einstein, et al.
Pageof 6